University Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India.
Drug Dev Ind Pharm. 2020 May;46(5):826-845. doi: 10.1080/03639045.2020.1757697. Epub 2020 May 15.
Agomelatine (AGM), an antidepressant drug has low biological half-life coupled with extensive hepatic first-pass metabolism. For effective treatment of depression, daily medication is required but irregular dose intake occurs due to psychological illness which can be overcome by development of transdermal drug delivery system. But for effective transdermal delivery permeation of AGM through stratum corneum is a crucial step. Thus present study was intended to formulate and optimize polymeric nanoparticles of agomelatine and to compare the effect of binary combinations of solvent system on permeability profiling of pure agomelatine with statistically optimized polymeric nanoparticles. Polymeric agomelatine nanoparticles (AGM-PNPs) were prepared by nano-precipitation method which was further optimized by experimental design and characterized by FTIR, DSC, XRD and SEM study while study was performed on adult male wistar rats. The optimized formulation has particle size in nano range (107.64 nm) with low PDI (0.209), stable zeta potential (-15 mV) and high entrapment efficiency (81.91%). analysis of optimized nanoparticles suggests that nanoparticles permeate faster compared to plain AGM, while, permeation profile of AGM was enhanced when combination of solvent systems were used. It was observed that among various solvent system 33% PG-ethanol showed maximum flux (148.48 ± 3.24 µg/cm/h) and least lag time (4.04 ± 0.12 h). The flux was further enhanced (180.98 ± 2.54 µg/cm/h) when 5%v/v transcutol-HP was added as penetration enhancer. The above observations concluded that binary combination of 33% PG-ethanol with 5 %v/v transcutol-HP can serve as a solvent system of choice for effective transdermal delivery of agomelatine via nanoparticulate system.
阿戈美拉汀(AGM)是一种抗抑郁药,其生物半衰期短,且具有广泛的肝脏首过代谢。为了有效治疗抑郁症,需要每天服药,但由于心理疾病,患者经常不规律地服药,这可以通过开发透皮给药系统来克服。但是,对于有效的透皮递送,AGM 通过角质层的渗透是至关重要的一步。因此,本研究旨在制备和优化阿戈美拉汀的聚合物纳米粒,并比较二元溶剂系统对纯阿戈美拉汀与经统计学优化的聚合物纳米粒的渗透特性的影响。通过纳米沉淀法制备聚合物阿戈美拉汀纳米粒(AGM-PNPs),进一步通过实验设计进行优化,并通过 FTIR、DSC、XRD 和 SEM 研究进行表征,同时在成年雄性 Wistar 大鼠上进行研究。优化的配方具有纳米级的粒径(107.64nm),低 PDI(0.209),稳定的zeta 电位(-15mV)和高包封效率(81.91%)。优化纳米粒的分析表明,与普通 AGM 相比,纳米粒渗透更快,而当使用溶剂系统组合时,AGM 的渗透特性得到增强。观察到,在各种溶剂系统中,33%PG-乙醇显示出最大的通量(148.48±3.24µg/cm/h)和最短的滞后时间(4.04±0.12h)。当加入 5%v/v 曲可伸作为渗透增强剂时,通量进一步增强(180.98±2.54µg/cm/h)。上述观察结果表明,33%PG-乙醇与 5%v/v 曲可伸的二元组合可以作为阿戈美拉汀经纳米粒系统有效透皮递送的首选溶剂系统。